Webinar

ASCO 2026: Key Highlights for Stomach/Gastric Cancer Patients

Event Main Image

This on‑demand webinar, originally aired June 9, 2026 (6  PM–7 PM CDT), brings together world‑renowned oncologists and a patient advocate to translate complex research into clear, actionable insights for patients, caregivers, and clinicians.

👩‍⚕️ Expert Panel

  • Dr. Yelena Janjigian – Memorial Sloan Kettering Cancer Center
  • Dr. Samuel Klempner – Harvard Medical School
  • Dr. Elena Elimova – Princess Margaret Cancer Centre
  • Frank Blandon – Patient Advocate

🔬 What You’ll Learn

  • Top new data and clinical developments from ASCO 2026 in gastric and GEJ cancers
  • How these findings impact current and future treatment decisions
  • Updates on HER2‑targeted therapies, immunotherapy combinations, and emerging biomarkers
  • Insights into ctDNA testing, minimal residual disease (MRD), and personalized care pathways
  • Expert perspectives on side‑effect management, treatment duration, and shared decision‑making

💡 Why Watch

This session delivers patient‑friendly, evidence‑based updates that help you stay informed about the most relevant and potentially practice‑changing advances in gastric cancer care. Whether you’re a patient, caregiver, or healthcare professional, you’ll gain clarity on where the field is heading next.

🤝 Partners

In collaboration with: Debbie’s Dream Foundation, Gastric Cancer Foundation, Hope for Stomach Cancer, My Gut Feeling, No Stomach for Cancer, and Stomach Cancer UK

Webinar
On June 9 2026, the GI Cancers Alliance and global advocacy partners hosted a webinar with an in‑depth look at the latest breakthroughs from the 2026 ASCO Annual Meeting—focused on what matters most for stomach and gastroesophageal junction (GEJ) cancer patients.
Download
Webinar
Arrow